1989
DOI: 10.1016/0024-3205(89)90593-6
|View full text |Cite
|
Sign up to set email alerts
|

Minireview Magnetically controlled targeted micro-carrier systems

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
71
0
1

Year Published

2002
2002
2014
2014

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 200 publications
(73 citation statements)
references
References 64 publications
1
71
0
1
Order By: Relevance
“…The magnetite nanoparticles were synthesized through the co-precipitation of ferrous and ferric hydroxides by addition of NH 4 OH to a solution of Fe(II) and Fe(III) salts at a 1:2 molar ratio under nitrogen atmosphere to prevent oxidation. Scanning electron microscopy was used to illustrate the morphology of magnetite nanoparticles.…”
Section: Synthesis Of Magnetite Nanoparticles (Mnps)mentioning
confidence: 99%
See 1 more Smart Citation
“…The magnetite nanoparticles were synthesized through the co-precipitation of ferrous and ferric hydroxides by addition of NH 4 OH to a solution of Fe(II) and Fe(III) salts at a 1:2 molar ratio under nitrogen atmosphere to prevent oxidation. Scanning electron microscopy was used to illustrate the morphology of magnetite nanoparticles.…”
Section: Synthesis Of Magnetite Nanoparticles (Mnps)mentioning
confidence: 99%
“…Magnetic iron oxide nanoparticles with tailored surface chemistry have been widely used experimentally for numerous in vivo applications such as magnetic resonance imaging, contrast enhancement, tissue repair, immunoassay, detoxification of biological fluids, hyperthermia, drug delivery and in cell separation [1][2][3][4][5]. Coating or modifying these nanoparticles with hydrophilic molecules, especially biomolecules, is a crucial step for the preparation of waterdispersible magnetite nanoparticles (MNPs) for use in biological applications [6].…”
Section: Introductionmentioning
confidence: 99%
“…In order to produce a depot in the target organ, a suitable magnet was kept (8000 Gaussauss/cm strength) on the head. It has been suggested that at the arterio-capillary blood flow rate of 0.005-0.1 cm/s, 20% (w/w) magnetite is sufficient to achieve 100% retention of the magnetic carrier using 8000 Gauss magnet [95], and these microparticles presented a magnetite content of 30% (w/w). There was a reduction in the accumulation of tacrine in the non-targeted organs liver, spleen and kidneys, when it was administered in the form of magnetic chitosan microparticles, compared to the free drug tacrine.…”
Section: Microparticles For Tacrine Deliverymentioning
confidence: 99%
“…초상 자성 재료는 강자성 재료에 비해 낮은 잔류자화와 보자력 값 을 갖기 때문에 인가된 자장에 민감하게 반응하여 cell separation, 1,2 cell labeling, [3][4][5] enzyme immunoassays, 6 nucleic acids concentration, 7 drug delivery processes, 8 …”
Section: ⅰ 서 론unclassified